副肿瘤性KLHL11脑炎的扩展临床表型、肿瘤关联及免疫病理见解
这项回顾性研究纳入39例KLHL11 IgG阳性患者,均为男性,中位年龄46岁。常见表现包括共济失调、复视、眩晕、听力下降和耳鸣。83%筛查肿瘤的患者发现睾丸生殖细胞肿瘤或退变迹象。多数患者对免疫和/或肿瘤治疗有获益,但无睾丸癌者轮椅依赖概率更高。
要点
- KLHL11脑炎多见于男性,常表现为共济失调、复视、眩晕、听力下降和耳鸣。
- 听力下降或耳鸣可先于其他神经症状1至8个月出现。
- 筛查肿瘤者中83%发现睾丸生殖细胞肿瘤或退变迹象。
核心结论
- KLHL11 IgG是睾丸生殖细胞肿瘤和副肿瘤性神经综合征的生物标志物,常对治疗抵抗。
研究设计与样本
- 回顾性 tertiary care center 研究,1998年10月15日至2019年11月1日,前瞻性识别31例KLHL11 IgG+病例,另8例通过回顾性检测菱形脑炎患者确认。
主要发现
- 所有39例患者均为男性,中位年龄46岁(范围28-73岁)。
- 初诊表现包括共济失调32例(82%)、复视22例(56%)、眩晕21例(54%)、听力下降15例(39%)、耳鸣14例(36%)、构音障碍11例(28%)、癫痫9例(23%)。
- 听力下降或耳鸣先于其他神经缺损1至8个月出现于10例(26%)。
- 筛查肿瘤的36例中,23例(64%)发现睾丸生殖细胞肿瘤,7例(19%)发现睾丸微石症和纤维化提示退变生殖细胞肿瘤,共30例(83%)。
- 2例淋巴结活检分别诊断转移性肺腺癌和慢性淋巴细胞白血病。
关键数值与推荐
- 初始脑MRI显示颞叶T2高信号12例、小脑9例、脑干3例、间脑3例。
- 10例HLA分型中,HLA-DQB1*02:01阳性7例(70%),HLA-DRB1*03:01阳性6例(60%)。
- 颞叶活检显示T细胞为主炎症和非坏死性肉芽肿;小脑活检和2例尸检显示浦肯野神经元丢失和Bergmann胶质增生。
- 患者外周血单核细胞与KLHL11蛋白共培养时,CD8+和CD4+ T细胞较非自身免疫对照显著活化。
- 58%患者从免疫和/或肿瘤治疗中获益(神经 disability 稳定10例,改善9例)。
临床怎么用
- 对表现为共济失调、复视、眩晕、听力下降或耳鸣的男性患者,应考虑检测KLHL11 IgG。
- KLHL11 IgG阳性者应筛查睾丸生殖细胞肿瘤及其他恶性肿瘤。
- 听力下降或耳鸣可能是早期线索,需警惕副肿瘤性神经综合征。
- 治疗可结合免疫治疗和肿瘤治疗,但部分患者反应不佳。
局限性
- 回顾性研究设计。
- 样本量较小(39例)。
- 部分数据来自回顾性检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Recognizing the presenting and immunopathological features of Kelch-like protein-11 immunoglobulin G seropositive (KLHL11 IgG+) patients may aid in early diagnosis and management. OBJECTIVE: To describe expanding neurologic phenotype, cancer associations, outcomes, and immunopathologic features of KLHL11 encephalitis. DESIGN, SETTING, AND PARTICIPANTS: This retrospective tertiary care center study, conducted from October 15, 1998, to November 1, 2019, prospectively identified 31 KLHL11 IgG+ cases in the neuroimmunology laboratory. Eight were identified by retrospective testing of patients with rhomboencephalitis (confirmed by tissue-based-immunofluorescence and transfected-cell-based assays). MAIN OUTCOMES AND MEASURES: Outcome variables included modified Rankin score and gait aid use. RESULTS: All 39 KLHL11 IgG+ patients were men (median age, 46 years; range, 28-73 years). Initial clinical presentations were ataxia (n = 32; 82%), diplopia (n = 22; 56%), vertigo (n = 21; 54%), hearing loss (n = 15; 39%), tinnitus (n = 14; 36%), dysarthria (n = 11; 28%), and seizures (n = 9; 23%). Atypical neurologic presentations included neuropsychiatric dysfunction, myeloneuropathy, and cervical amyotrophy. Hearing loss or tinnitus preceded other neurologic deficits by 1 to 8 months in 10 patients (26%). Among patients screened for malignancy (n = 36), testicular germ-cell tumors (n = 23; 64%) or testicular microlithiasis and fibrosis concerning for regressed germ cell tumor (n = 7; 19%) were found in 83% of the patients (n = 30). In 2 patients, lymph node biopsy diagnosed metastatic lung adenocarcinoma in one and chronic lymphocytic leukemia in the other. Initial brain magnetic resonance imaging revealed T2 hyperintensities in the temporal lobe (n = 12), cerebellum (n = 9), brainstem (n = 3), or diencephalon (n = 3). Among KLHL11 IgG+ patients who underwent HLA class I and class II genotyping (n = 10), most were found to have HLA-DQB1*02:01 (n = 7; 70%) and HLA-DRB1*03:01 (n = 6; 60%) associations. A biopsied gadolinium-enhancing temporal lobe lesion demonstrated T cell-predominant inflammation and nonnecrotizing granulomas. Cerebellar biopsy (patient with chronic ataxia) and 2 autopsied brains demonstrated Purkinje neuronal loss and Bergmann gliosis, supporting early active inflammation and later extensive neuronal loss. Compared with nonautoimmune control peripheral blood mononuclear cells, cluster of differentiation (CD) 8+ and CD4+ T cells were significantly activated when patient peripheral blood mononuclear cells were cultured with KLHL11 protein. Most patients (58%) benefitted from immunotherapy and/or cancer treatment (neurological disability stabilized [n = 10] or improved [n = 9]). Kaplan-Meier curve demonstrated significantly higher probability of wheelchair dependence among patients without detectable testicular cancer. Long-term outcomes in KLHL11-IgG+ patients were similar to Ma2 encephalitis. CONCLUSIONS AND RELEVANCE: Kelch-like protein-11 IgG is a biomarker of testicular germ-cell tumor and paraneoplastic neurologic syndrome, often refractory to treatment. Described expanded neurologic phenotype and paraclinical findings may aid in its early diagnosis and treatment.
引用
- Dubey D, Wilson MR, Clarkson B, et al. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. JAMA Neurol. 2020. PMID: 32744608. doi:10.1001/jamaneurol.2020.2231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。